Agreement | AIA vs ARC | CEN vs ARC | CL2 vs ARC | COB vs ARC | IMM vs ARC | KRY vs ARC | LIA vs ARC | LUM vs ARC | MAG VS ARC | PHA vs ARC |
---|
No. | 120 | 120 | 120 | 120 | 120 | 120 | 120 | 120 | 120 | 120 |
Bias % (±1.96 SD) | −37 (78.7 to −152.6) | 133.6 (219.2 – 48) | −115.8 (−45.1 to −186.6) | 155.1 (194.3–115.9) | −54.6 (106.8–216.1) | 125.8 (226.7–24.8) | 141.8 (189.5–94) | 125 (188.3–61.7) | 156.4 (201.7–111) | 147.2 (190.1–104.2) |
-
AIA AIA-2000, Tosoh Bioscience, ARC Architect, Abbott Diagnostics, CEN Advia Centaur XP, Siemens Healthineers, CI confidence intervals, CL2 AIA CL-2400, Tosoh Bioscience, COB Cobas 6000, Roche Diagnostics, e-URL experimental upper reference limit, IMM Immulite 2000 XPi, Siemens Healthineers, KRY Kryptor, Thermo Fisher Scientific BRAHMS, LIA Liaison XL, Diasorin, LUM Lumipulse G, Fujirebio, m-URL manufacturer upper reference limit, MAG Maglumi 2000 Plus, Snibe, No. number, PHA Phadia 250, Phadia AB, Thermo Fisher Scientific, r
s Spearman’s rank correlation coefficient